302 related articles for article (PubMed ID: 31058448)
1. Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures.
Liu Z; Li CW; Mao YF; Liu K; Liang BC; Wu LG; Shi XL
Orthop Surg; 2019 Jun; 11(3):380-385. PubMed ID: 31058448
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail anti-rotation.
Li Y; Zhao WB; Wang DL; He Q; Li Q; Pei FX; Liu L
Chin J Traumatol; 2016 Oct; 19(5):259-263. PubMed ID: 27780504
[TBL] [Abstract][Full Text] [Related]
3. After the fall: improving osteoporosis treatment following hip fracture.
Kuiper BW; Graybill S; Tate JM; Kaufman N; Bersabe D
Osteoporos Int; 2018 Jun; 29(6):1295-1301. PubMed ID: 29464276
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures.
Liu B; Gan F; Ge Y; Yu H
J Invest Surg; 2018 Oct; 31(5):425-430. PubMed ID: 28829670
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures.
Huang TW; Chuang PY; Lin SJ; Lee CY; Huang KC; Shih HN; Lee MS; Hsu RW; Shen WJ
Medicine (Baltimore); 2016 May; 95(19):e3626. PubMed ID: 27175673
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
Zhu K; Zhang J; Zhang C; Zhao Z; Gao J; Li X; Xia X; Xu X; Zhang T; Guan J
Osteoporos Int; 2021 Mar; 32(3):559-564. PubMed ID: 32989470
[TBL] [Abstract][Full Text] [Related]
7. Short-term daily teriparatide improve postoperative functional outcome and fracture healing in unstable intertrochanteric fractures.
Kim SJ; Park HS; Lee DW; Lee JW
Injury; 2019 Jul; 50(7):1364-1370. PubMed ID: 31182230
[TBL] [Abstract][Full Text] [Related]
8. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
[TBL] [Abstract][Full Text] [Related]
9. Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
Prieto-Alhambra D; Judge A; Arden NK; Cooper C; Lyles KW; Javaid MK
Osteoporos Int; 2014 Jan; 25(1):77-83. PubMed ID: 23812596
[TBL] [Abstract][Full Text] [Related]
10. Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture.
Cobden A; Cobden SB; Camurcu Y; Ucpunar H; Duman S; Sofu H
Arch Osteoporos; 2019 Oct; 14(1):100. PubMed ID: 31628566
[TBL] [Abstract][Full Text] [Related]
11. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
Cheung MY; Ho AW; Wong SH
Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
[TBL] [Abstract][Full Text] [Related]
12. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
[TBL] [Abstract][Full Text] [Related]
13. Denosumab versus zoledronic acid in elderly patients after hip fracture.
Kim SJ; Kim JW; Lee DW
J Orthop Surg (Hong Kong); 2022; 30(3):10225536221147082. PubMed ID: 36541833
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces.
Crilly RG; Kloseck M; Chesworth B; Mequanint S; Sadowski E; Gilliland J
Osteoporos Int; 2014 Jan; 25(1):205-10. PubMed ID: 23907572
[TBL] [Abstract][Full Text] [Related]
15. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
Zhou W; Liu Y; Guo X; Yang H; Xu Y; Geng D
Osteoporos Int; 2019 Aug; 30(8):1581-1589. PubMed ID: 31115592
[TBL] [Abstract][Full Text] [Related]
16. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
[TBL] [Abstract][Full Text] [Related]
18. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
19. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
[TBL] [Abstract][Full Text] [Related]
20. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?
Kim TY; Ha YC; Kang BJ; Lee YK; Koo KH
J Bone Joint Surg Br; 2012 Jul; 94(7):956-60. PubMed ID: 22733953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
